Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy.

Ye-Xuan CaoJing-Lu JinDi SunHui-Hui LiuYuan-Lin GuoNa-Qiong WuRui-Xia XuCheng-Gang ZhuQian DongJing SunJian-Jun Li

Published in: Journal of translational medicine (2019)

Elevated levels of PCSK9 were positively associated with the development of CAD and future cardiovascular events, suggesting that measurement of PCSK9 concentration might be useful for cardiovascular risk stratification. Further studies are needed to confirm our results.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
low density lipoprotein
current status
type diabetes
fatty acid
bone marrow
mesenchymal stem cells